Opendata, web and dolomites

ClarifyLupus

Launching the Breakthrough in Lupus Diagnostics

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ClarifyLupus project word cloud

Explore the words cloud of the ClarifyLupus project. It provides you a very rough idea of what is the project "ClarifyLupus" about.

stating    25m    lives    rule    ethical    discovery    antunes    expert    members    clarify    earlier    patients    quantifying    atilde    alone    perform    january    approval    clarifylupus    market    autoantibodies    egas    2017    disease    stage    alexandra    confounding    samples    biomarker    portugal    diagnosing    recruiting    toxicology    altered    competitors    diseases    damages    later    2018    spectroscopy    irreversible    unavailability    contrast    confirm    start    usa    until    acceleration    difficulty    founded    jo    business    prestigious    methodology    decades    play    blood    occurrence    stages    lupus    rodrigues    quality    committee    lisbon    conducting    breakthrough    tested    april    team    hospital    overlapping    clinical    assays    letter    worse    onset    devastating    disruption    lab    6m    cohitech    13    symptoms    8m    proof    passed    mass    autoimmune    portuguese    moniz    diagnosis    technologists    diagnostic    secured    proteins    unspecific    analytical    diagnosed    people   

Project "ClarifyLupus" data sheet

The following table provides information about the project.

Coordinator
CLARIFY ANALYTICAL LDA 

Organization address
address: RUA DE MERCADORES 128A
city: EVORA
postcode: 7000-872
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Portugal [PT]
 Project website http://www.clarifyanalytical.pt/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-03-01   to  2019-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CLARIFY ANALYTICAL LDA PT (EVORA) coordinator 50˙000.00

Map

 Project objective

The difficulty on diagnosing lupus is due not only to the occurrence of overlapping symptoms with other autoimmune diseases but also to the unavailability of a lab test to confirm or rule out Lupus. The autoimmune disease is devastating, and the later it is diagnosed, the worse are the irreversible damages to the patients. In the USA alone, there are 13.8M people with Lupus and overlapping diseases and 2,6M new cases of these diseases are diagnosed each year. These diseases affect more than 25M people in the EU. We have developed a technology capable of identifying and quantifying altered proteins that play a key role in the onset of Lupus. Our product ClarifyLupus is a diagnostic test that is effective since the early stages of the disease. Although our competitors are conducting research on Lupus biomarker discovery, they all are focused in autoantibodies biomarker discovery that are highly unspecific among Lupus-confounding diseases. In contrast we have a Lupus-specific biomarker that enables the Lupus diagnosis much earlier than our competitors. We have passed the proof-of-concept stage where our diagnosis methodology was tested in blood samples and in January 2018 we have secured the Portuguese ethical committee approval to perform clinical assays, and are recruiting 50 patients until the end of the year. In April 2018 we secured a Letter of Support from the Egas Moniz Hospital in Lisbon, stating the importance and market disruption of ClarifyLupus. Clarify Analytical was founded in 2017 by Alexandra Antunes and João Rodrigues, two expert technologists in the fields of toxicology and mass spectroscopy, supported by 3 team members. The start-up was selected for the prestigious CoHiTech acceleration program in Portugal, focused on business and technology go-to-market. ClarifyLupus will be the breakthrough for Lupus diagnosis which will allow Lupus patients to be treated earlier, extending their lives by decades and improving their quality.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CLARIFYLUPUS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CLARIFYLUPUS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DNA DS (2019)

DNA Data storage

Read More  

ERGOVIAkinematix (2018)

New wearable measurement devices for Industry 4.0 based on gaming motion-capture system

Read More  

Totem Spoon (2019)

Interactive Digital Signage with emotional intelligence for smart cities

Read More